CHPA to expand Five Moms to Latino community
WASHINGTON The Consumer Healthcare Products Association on Friday announced the expansion of its Five Moms Campaign—a grass-roots campaign to help raise awareness around teen cough medicine abuse—to reach Hispanic audiences with additional Spanish-language content and utilities.
The latest addition is a tool, called tell-a-friend, to help Spanish-speaking parents communicate the Five Moms message of awareness with other Spanish-speaking parents, the association stated.
The Five Moms tell-a-friend feature is an easy-to-use tool to help Spanish speakers share information and resources in order to prevent teen cough medicine abuse. The feature joins new content and an entire en Espanol section on FiveMoms.com.
P&G’s ThermaCare acquired by Wyeth Consumer Healthcare
MADISON, N.J. Wyeth Consumer Healthcare’s acquisition of Procter &Gamble’s ThermaCare brand has been finalized, Wyeth reported, according to published reports.
Terms were not disclosed.
ThermaCare, the leading brand in the heat/ice pack category as measured by Information Resources, Inc., generated sales of $51.1 million for the 52 weeks ended July 13, across food, drug and mass (minus Wal-Mart) channels.
ThermaCare fits Wyeth’s strategy to accelerate growth through innovation, organic geographic growth and strategic acquisitions in the division’s base business, which includes pain management, respiratory, nutritional, gastrointestinal and topical products, the company stated in announcing the deal in July.
ThermaCare will join the company’s pain franchise that includes Advil.
The heat wraps are manufactured in Albany, Ga., in a facility that will be maintained by Wyeth.
N.J. legislators propose age verification to purchase OTC cough/cold medicines
TRENTON, N.J. Two New Jersey lawmakers are proposing a ban on the sale of some cough/cold products to minors out of concern for potential abuse—most notably the abuse of the cough suppressant dextromethorphan—in a bill to be introduced this fall, according to a report in Newsday published Wednesday.
The bill is being proposed by Sens. Barbara Buono, D-Edison, N.J., and Tom Kean, Jr., R-Westfield, N.J., and would require retailers to verify a customer’s age before selling any product containing DXM.
The industry in the past has supported both federal and retail efforts to implement sales restrictions prohibiting the purchase of products containing dextromethorphan by those under the age of 18. In 2007, Sen. Joseph Biden, D-Del., introduced S. 2274, the Dextromethorphan Abuse Reduction Act, which would prevent teens under the age of 18 from purchasing cough medicine containing dextromethorphan, a bill that was supported by the Consumer Healthcare Products Association, the Community Anti-Drug Coalitions of America, the Food Marketing Institute, the National Association of Chain Drug Stores, and the Parternship for a Drug-Free America.
Most retailers already require cashiers to verify the age of the consumer before selling DXM products.
“DXM abuse can have lasting and potentially fatal consequences for teenagers who misuse this legal, inexpensive and easily accessible substance in order to achieve a high,” Buono told the New York regional daily.